Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Laurence, Wood"'
Autor:
Behnam Noorani, Ekram Ahmed Chowdhury, Faleh Alqahtani, Yeseul Ahn, Ehsan Nozohouri, Sumaih Zoubi, Dhavalkumar Patel, Laurence Wood, Juyang Huang, Muhammad Bilal Siddique, Abraham Al-Ahmad, Reza Mehvar, Ulrich Bickel
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 385:135-145
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11159309ed38a717a511cb3024eee79f
https://doi.org/10.1124/jpet.122.001281
https://doi.org/10.1124/jpet.122.001281
Publikováno v:
Breast Cancer. 30:167-186
Heterogeneity of the tumor microenvironment (TME) and the lack of a definite targetable receptor in triple-negative breast cancer (TNBC) has carved a niche for this cancer as a particularly therapeutically challenging form of breast cancer. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f6924a48a66494a6277802076a89963
https://doi.org/10.1007/s12282-022-01415-4
https://doi.org/10.1007/s12282-022-01415-4
Autor:
Hong-My Nguyen, Laurence Wood
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9d8569b96e41cd0b996b07a546281ca
https://doi.org/10.1136/jitc-2022-sitc2022.1370
https://doi.org/10.1136/jitc-2022-sitc2022.1370
Publikováno v:
Cancer Research. 83:LB201-LB201
Background: Colorectal cancer (CRC) has been a difficult-to-treat cancer with a significant proportion of microsatellite stable (MSS-CRC) patients who do not respond to immunotherapy. Currently, various strategies are being investigated to sensitize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00720509ba04d8f8f1d1e2daa1edc412
https://doi.org/10.1158/1538-7445.am2023-lb201
https://doi.org/10.1158/1538-7445.am2023-lb201
Publikováno v:
Seminars in cancer biology. 88
Cancer vaccines and immune checkpoint inhibitors (ICIs) function at different stages of the cancer immune cycle due to their distinct mechanisms of action. Therapeutic cancer vaccines enhance the activation and infiltration of cytotoxic immune cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eccf14460caffe100e19897d7c872cb1
https://pubmed.ncbi.nlm.nih.gov/36526110
https://pubmed.ncbi.nlm.nih.gov/36526110
Publikováno v:
Cancer Immunology Research. 10:A68-A68
Anti-cancer vaccines are consequential and useful tools in eliciting long-term immune responses against tumor-associated antigens (TAAs). Attenuated listeria monocytogenes represents one such vaccine modality for inducing durable immune-driven respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3416df602e224c8140881461a4808e76
https://doi.org/10.1158/2326-6074.tumimm22-a68
https://doi.org/10.1158/2326-6074.tumimm22-a68
Autor:
Constantinos M. Mikelis, Vasileios Oikonomou, Mihalis S. Lionakis, Laurence Wood, Fatema Tuz Zahra, Racheal G Akwii, Sanaullah Sajib, Paul Tullar
Publikováno v:
The FASEB Journal. 35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::264efed704ec9504e74a0f58bc0c4cf1
https://doi.org/10.1096/fasebj.2021.35.s1.04971
https://doi.org/10.1096/fasebj.2021.35.s1.04971
Autor:
Kara A. Gray-Burrows, Allison Chin, Robbie Foy, Kirsty Samuel, Thomas A. Willis, Pauline Bland, Susan Hodgson, Rosemary R. C. McEachan, Gus Ibegbuna, Martin Rathfelder, Graham Prestwich, Laurence Wood, Farhat Yaqoob
Publikováno v:
BMJ Quality & Safety
BackgroundPatient and public involvement (PPI) is often an essential requirement for research funding. Distinctions can be drawn between clinical research, which generally focuses on patients, and implementation research, which generally focuses on h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80f686a1469b44abf6279e16fa7ed7f1
http://europepmc.org/articles/PMC6166593
http://europepmc.org/articles/PMC6166593
Publikováno v:
Lecture Notes in Business Information Processing ISBN: 9783319576329
XP
XP
Knowledge is a core resource for agile organisations that is transformed into products and services during the development process. Sharing of knowledge is essential across any organisation, and it has been claimed that the software industry requires
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::996fb718fd5cb1b42c0490d0528eff3e
https://clok.uclan.ac.uk/18793/1/18793.pdf
https://clok.uclan.ac.uk/18793/1/18793.pdf
